Interleukin-1 beta — Drug Target

All drugs that target Interleukin-1 beta — marketed and clinical-stage. Includes 1 drug classes acting on this target.

Drug classes

Non-Standardized Plant Allergenic Extract [EPC]

Marketed (2)

• Ilaris · Novartis Pharms · Non-Standardized Plant Allergenic Extract [EPC] · Immunology
• Arcalyst · Regeneron · Rare Disease
  Arcalyst works by binding to Interleukin-1 beta, preventing its interaction with its receptor and reducing inflammation.